Campbell & Co. Investment Adviser »

Bridgebio Pharma shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.6M 35k 74.48
2025-06-30 $1.5M 35k 43.18
2023-09-30 $403k 15k 26.37

More positions owned by Campbell & Co. Investment Adviser

Hilton Worldwide Holdings Common Stock (HLT)
Petroleo Brasileiro SA - Petro Adr (PBR)
Darling Ingredients Common Stock (DAR)
Hartford Insurance Group Inc/T Common Stock (HIG)
Atmos Energy Corp Common Stock (ATO)
Marriott International Common Stock (MAR)
LyondellBasell Industries NV Common Stock (LYB)
Westlake Corp Common Stock (WLK)
Mettler-Toledo International I Common Stock (MTD)
Labcorp Holdings Common Stock (LH)
Loews Corp Common Stock (L)
US Bancorp Common Stock (USB)
Primerica Common Stock (PRI)
Mastercard Common Stock (MA)
Wells Fargo & Co Common Stock (WFC)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Bridgebio Pharma

Jupiter Topco
Kohlberg Kravis Roberts & Co
Henderson Group
Farallon Capital Management
BlackRock
Viking Global Investors
Vanguard Capital Management
Vanguard Portfolio Management
Jane Street
UBS Group
Wellington Management Company
State Street Corporation
Two Sigma Investments
Aisling Capital Management
Citadel Advisors

View all funds holding Bridgebio Pharma